Zdrowie i gospodarka · 16/02/2016
FDA Releases Draft Guidance for Cyclosporine Ophthalmic Emulsion
The FDA has made available a revised draft guidance for industry on the design of bioequivalence studies to support abbreviated new drug applications for cyclosporine ophthalmic emulsion, a treatment for eye conditions.
Source: Federal Register — Food and Drug AdministrationOpen original release →